Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization
Table 3
In-hospital outcomes.
Adverse Events
All
CABG ineligible
CABG eligible
p-value
(N=331)
(N=227)
(N=104)
MACCE
6.95% (23/331)
6.61% (15/227)
7.69% (8/104)
0.816
Death
4.23% (14/331)
3.52% (8/227)
5.77% (6/104)
0.382
Myocardial Infarction
2.42% (8/331)
2.64% (6/227)
1.92% (2/104)
1.000
Stroke
0.00% (0/331)
0.00% (0/227)
0.00% (0/104)
- -
Repeat Revascularization
0.60% (2/331)
0.44% (1/227)
0.96% (1/104)
0.530
Acute Renal Dysfunction
4.83% (16/331)
3.52% (8/227)
7.69% (8/104)
0.164
Aortic Valve Regurgitation
0.00% (0/331)
0.00% (0/227)
0.00% (0/104)
- -
Hypotension During Support
3.93% (13/331)
4.41% (10/227)
2.88% (3/104)
0.762
Cardiopulmonary Resuscitation or Ventricular Arrhythmia
2.72% (9/331)
2.20% (5/227)
3.85% (4/104)
0.470
CABG: coronary artery bypass grafting; MACCE: major adverse cardiac and cerebrovascular events (death, stroke, myocardial infarction, and repeat revascularization).
